Credit Suisse’s BIO-key International BKYI Stock Holding History

Credit Suisse’s Portfolio BKYI Stock Details BKYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-78	Closed	-$49K	–	4449
2021 Q1	$49K	Buy	+78	New	+$56.3K	﹤0.01%	4227

Other funds holding BKYI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Credit Suisse's BKYI Position: Q2 2021 in Review

Credit Suisse sold out of BIO-key International (BKYI) in Q2 2021, closing a stake of 78 shares — an estimated $49K sold.

Credit Suisse first reported a position in BKYI in Q1 2021 and held it in 1 quarter. The position peaked at $49K in Q1 2021. 13 funds tracked by Wall St. Rank hold BKYI as of Q2 2021.

Credit Suisse reported no remaining BIO-key International position as of Q2 2021 after selling out during the quarter.
Credit Suisse sold 78 BIO-key International shares in Q2 2021, an estimated $49K.
Credit Suisse first reported a position in BIO-key International in Q1 2021 and held it in 1 quarter.
Credit Suisse's BIO-key International position peaked at $49K in Q1 2021.
13 funds tracked by Wall St. Rank held BIO-key International as of Q2 2021.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.